Cargando…

Neutralizing Antibodies Limit Cell-Associated Spread of Human Cytomegalovirus in Epithelial Cells and Fibroblasts

Human cytomegalovirus (HCMV) can cause severe clinical disease in immunocompromised individuals, such as allograft recipients and infants infected in utero. Neutralizing activity of antibodies, measured as the ability to prevent the entry of cell-free virus, has been correlated with the reduction in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Reuter, Nina, Kropff, Barbara, Britt, William J., Mach, Michael, Thomas, Marco
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8875165/ https://www.ncbi.nlm.nih.gov/pubmed/35215877 http://dx.doi.org/10.3390/v14020284

Ejemplares similares

Protective capacity of neutralizing and non-neutralizing antibodies against glycoprotein B of cytomegalovirus
por: Bootz, Anna, et al.
Publicado: (2017)

Glycoprotein N of Human Cytomegalovirus Protects the Virus from Neutralizing Antibodies
por: Kropff, Barbara, et al.
Publicado: (2012)

SARS-CoV-2 Spike Protein Is Capable of Inducing Cell–Cell Fusions Independent from Its Receptor ACE2 and This Activity Can Be Impaired by Furin Inhibitors or a Subset of Monoclonal Antibodies
por: Reuter, Nina, et al.
Publicado: (2023)

Neutralization of Human Cytomegalovirus Entry into Fibroblasts and Epithelial Cells
por: Wussow, Felix, et al.
Publicado: (2017)

Human Cytomegalovirus Envelope Protein gpUL132 Regulates Infectious Virus Production through Formation of the Viral Assembly Compartment
por: Wu, Hui, et al.
Publicado: (2020)

Detection of antibody-secreting cells specific for the cytomegalovirus and herpes simplex virus surface antigens
por: Alt, Mira, et al.
Publicado: (2018)

Neutralizing Monoclonal Antibodies Reduce Human Cytomegalovirus Infection and Spread in Developing Placentas
por: Tabata, Takako, et al.
Publicado: (2019)

Differences in Growth Properties among Two Human Cytomegalovirus Glycoprotein O Genotypes
por: Kalser, Julia, et al.
Publicado: (2017)

B Cell Repertoire Analysis Identifies New Antigenic Domains on Glycoprotein B of Human Cytomegalovirus which Are Target of Neutralizing Antibodies
por: Pötzsch, Sonja, et al.
Publicado: (2011)

Structural Basis for the Recognition of Human Cytomegalovirus Glycoprotein B by a Neutralizing Human Antibody
por: Spindler, Nadja, et al.
Publicado: (2014)

Fibroblast, Epithelial and Endothelial Cell-Derived Human Cytomegalovirus Strains Display Distinct Neutralizing Antibody Responses and Varying Levels of gH/gL Complexes
por: Fornara, Chiara, et al.
Publicado: (2023)

The Molecular Tweezer CLR01 Inhibits Antibody-Resistant Cell-to-Cell Spread of Human Cytomegalovirus
por: Brenner, Sina, et al.
Publicado: (2021)

Comparative neutralizing potencies of antibodies suggest conservation as well as mechanistic differences in human cytomegalovirus entry into epithelial and endothelial cells
por: Qi, Ying, et al.
Publicado: (2020)

2591. The Role of Neutralizing Antibodies (nAb) Against Cytomegalovirus (CMV) Epithelial Cell-entry in Patients with Self-limited (SL) CMV infection after Hematopoietic Cell Transplantation (HCT)
por: Zamora, Danniel, et al.
Publicado: (2019)

Human Cytomegalovirus Induces TGF-β1 Activation in Renal Tubular Epithelial Cells after Epithelial-to-Mesenchymal Transition
por: Shimamura, Masako, et al.
Publicado: (2010)

Murine Cytomegalovirus Spreads by Dendritic Cell Recirculation
por: Farrell, Helen E., et al.
Publicado: (2017)

Murine cytomegalovirus reactivation concomitant with acute graft-versus-host disease is controlled by antibodies
por: Seefried, Martina, et al.
Publicado: (2023)

Role of Envelope Glycoprotein Complexes in Cell-Associated Spread of Human Cytomegalovirus
por: Weiler, Nina, et al.
Publicado: (2021)

Association of human cytomegalovirus (HCMV) neutralizing antibodies with antibodies to the HCMV glycoprotein complexes
por: Shibamura, Miho, et al.
Publicado: (2020)

Impact of Sequence Variation in the UL128 Locus on Production of Human Cytomegalovirus in Fibroblast and Epithelial Cells
por: Murrell, Isa, et al.
Publicado: (2013)

Development of broadly neutralizing antibodies targeting the cytomegalovirus subdominant antigen gH
por: Parsons, Andrea J., et al.
Publicado: (2022)

Neutralization Epitopes in Trimer and Pentamer Complexes Recognized by Potent Cytomegalovirus-Neutralizing Human Monoclonal Antibodies
por: Ai, Yuanbao, et al.
Publicado: (2022)

Human cytomegalovirus transcriptome activity differs during replication in human fibroblast, epithelial and astrocyte cell lines
por: Towler, James C., et al.
Publicado: (2012)

Genome sequences of human cytomegalovirus strain TB40/E variants propagated in fibroblasts and epithelial cells
por: Al Qaffas, Ahmed, et al.
Publicado: (2021)

Atypical patterns of human cytomegalovirus infection and spread in U373 glioblastoma cells
por: Kalavacharla, Anusha, et al.
Publicado: (2023)

Generation of potent neutralizing human monoclonal antibodies against cytomegalovirus infection from immune B cells
por: Funaro, Ada, et al.
Publicado: (2008)

Human Cytomegalovirus pUL11, a CD45 Ligand, Disrupts CD4 T Cell Control of Viral Spread in Epithelial Cells
por: Osanyinlusi, Samuel A., et al.
Publicado: (2022)

Control of Murine Cytomegalovirus Infection by γδ T Cells
por: Sell, Sabrina, et al.
Publicado: (2015)

Polymorphic Forms of Human Cytomegalovirus Glycoprotein O Protect against Neutralization of Fibroblast Entry by Antibodies Targeting Epitopes Defined by Glycoproteins H and L
por: He, Li, et al.
Publicado: (2022)

The cytomegalovirus gB/MF59 vaccine candidate induces antibodies against an antigenic domain controlling cell-to-cell spread
por: Gomes, A. C., et al.
Publicado: (2023)

Cytomegalovirus-specific neutralizing antibodies effectively prevent uncontrolled infection after allogeneic hematopoietic stem cell transplantation
por: Wang, Huiru, et al.
Publicado: (2022)

Epitope-Specific Humoral Responses to Human Cytomegalovirus Glycoprotein-B Vaccine With MF59: Anti-AD2 Levels Correlate With Protection From Viremia
por: Baraniak, Ilona, et al.
Publicado: (2018)

Antibodies are not essential for the resolution of primary cytomegalovirus infection but limit dissemination of recurrent virus
Publicado: (1994)

Human Cytomegalovirus Reactivation During Lactation: Impact of Antibody Kinetics and Neutralization in Blood and Breast Milk
por: Lazar, Katrin, et al.
Publicado: (2020)

Cancer‐associated fibroblasts educate normal fibroblasts to facilitate cancer cell spreading and T‐cell suppression
por: Itoh, Go, et al.
Publicado: (2021)

Limited replication of human cytomegalovirus in a trophoblast cell line
por: Hyde, Kadeem, et al.
Publicado: (2021)

Requirement for HLA-DR+ accessory cells in natural killing of cytomegalovirus-infected fibroblasts
Publicado: (1986)

Maternal Immunity and the Natural History of Congenital Human Cytomegalovirus Infection
por: Britt, William J.
Publicado: (2018)

Cytomegalovirus Infection and Inflammation in Developing Brain
por: Krstanović, Fran, et al.
Publicado: (2021)

Dependence on a variable residue limits the breadth of an HIV MPER neutralizing antibody, despite convergent evolution with broadly neutralizing antibodies
por: Scheepers, Cathrine, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_t8994tqhf0dvt2bkaifq66pg3o